Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-kappaB-independent,

Craig McFarlane1, Erin Plummer, Mark Thomas

  • 1AgResearch, Functional Muscle Genomics, East Street, Hamilton, New Zealand.

Insights

Myostatin triggers muscle wasting (cachexia) by reducing muscle cell growth and increasing protein breakdown, independent of NF-kappaB signaling. It disrupts the AKT-FoxO1 pathway, promoting atrophy.

Area of Science:

  • Muscle biology
  • Molecular signaling
  • Cellular atrophy

Background:

  • Myostatin, a TGF-beta protein, negatively regulates muscle mass.
  • Muscle wasting conditions like cachexia are linked to elevated myostatin.
  • The precise molecular mechanisms of myostatin-induced cachexia are not fully understood.

Purpose of the Study:

  • To investigate the mechanism by which myostatin induces cachexia.
  • To determine if myostatin's effect on muscle wasting involves NF-kappaB.
  • To elucidate the signaling pathways affected by myostatin.

Main Methods:

  • In vitro studies on myotube number and size.
  • In vivo body mass measurements.
  • Analysis of myogenic gene expression (myoD, pax3) and NF-kappaB.
  • Promoter analysis for gene regulation.
  • Assessment of ubiquitin-proteolysis gene expression (atrogin-1, MuRF-1, E214k).
  • Investigation of the IGF-1/PI3K/AKT/FoxO1 signaling pathway.

Main Results:

  • Myostatin treatment reduced myotube size and number in vitro, and body mass in vivo.
  • Myostatin decreased myoD and pax3 expression without altering NF-kappaB.
  • Expression of atrophy-related genes (atrogin-1, MuRF-1, E214k) increased.
  • Myostatin inhibited AKT phosphorylation, activating FoxO1 and upregulating atrophy genes.
  • These effects were independent of NF-kappaB.

Conclusions:

  • Myostatin induces cachexia via an NF-kappaB-independent pathway.
  • Myostatin antagonizes muscle hypertrophy signaling by modulating the AKT-FoxO1 pathway.
  • Targeting myostatin or its downstream signaling may offer therapeutic strategies for muscle wasting.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...